Blood Flow Restriction Training for Treatment of Chronic Patellar Tendinopathy

January 17, 2023 updated by: Mikkel Holm Hjortshøj Jensen, Bispebjerg Hospital

The Effect of Low-Load Resistance Training With Blood Flow Restriction for Treatment of Chronic Patellar Tendinopathy - A Randomized Clinical Trial

The purpose of this study is to investigate the clinical and functional outcome of a 12-week rehabilitation regime consisting of Low-Load Blood Flow Restriction compared to Heavy-Slow Resistance training in male patients with chronic unilateral patellar tendinopathy.

Study Overview

Detailed Description

Chronic tendinopathy represents a considerable problem in both elite and recreational athletes, and symptoms may affect athletic performance and reduce or even result in retirement from sports participation. The current best treatment is considered to be heavy-slow resistance training (HSRT); however, not all patients are able to cope with heavy exercise loads. Therefore, low-load strength training performed under partial blood flow restriction may be a clinically relevant rehabilitation tool.

This project aims to investigate a new innovative intervention to treat chronic unilateral patellar tendinopathy in male individuals using strength training with low-load muscle contractions performed under partial blood flow restriction (LL-BFR), and to compare the resulting treatment outcome to that of the current best practice (HSRT). Specifically, the effect of LL-BFR will be investigated using a randomized controlled trial design with two groups; 1) a low-load blood flow restriction training program, and 2) a heavy-load slow strength training program. A total sample size of 36 participants are needed when assuming a 10 % dropout.

The training protocol consist of three weekly training sessions during a 12-week rehabilitation period. The primary outcome is measured using the Single-Leg Decline Squat at 12-week.

If LL-BFR proves to be an effective treatment strategy for tendinopathy, it can easily be implemented in daily clinical practice.

Study Type

Interventional

Enrollment (Actual)

36

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Copenhagen, Denmark, 2400
        • Department of Physical and Occupational Therapy / Institute of Sports Medicine Copenhagen, Bispebjerg Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 70 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Description

Inclusion Criteria:

  • Unilateral patellar tendinopathy
  • Chronic (symptoms >3 months)
  • Pain of ≥ 4 during preferred sporting activity on the numerical pain rating scale (NRS; with 0 being no pain and 10 being the worst imaginable pain)
  • Ultrasonographical tendon swelling
  • Ultrasonographical hypo-echoic area with doppler

Exclusion Criteria:

  • Bilateral tendinopathy
  • Cardiovascular diseases
  • Diabetes
  • Smoking
  • Previous surgery or trauma to the knee joint with an effect on the presenting clinical condition
  • Participants must not have been enrolled in a resistance based-rehabilitation program for the affected patellar tendon within the previous three months
  • Previous corticosteroid injection for patellar tendinopathy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Heavy-Slow Resistance training
Heavy-Slow Resistance training. Three times weekly for 12 weeks.
Resistance training for knee extensors. The exercise will be performed at 80% of 1 RM and slowly (6 s/repetition).
Experimental: Low-Load Blood Flow Restriction training
Low-Load Blood Flow Restriction training. Three times weekly for 12 weeks
Resistance training for knee extensors. The exercise will be performed at 30% of 1 RM and with a relative Artery Occlusion Pressure of 80%

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline - 12 weeks using the clinical functional test Single-Leg Decline Squat measured on the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)
Time Frame: Baseline-12 weeks.
Single-Leg Decline Squat is a reliable patellar tendon pain provocation test used to assess pain during function.
Baseline-12 weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Single-Leg Decline Squat test
Time Frame: Baseline, 3, 6 weeks + 1 year follow-up
A reliable patellar tendon pain provocation test, will be used to assess pain during function using the Numerical Rating Scale (NRS; 0= no pain, 10 = worst imaginable pain)
Baseline, 3, 6 weeks + 1 year follow-up
Pain rating on Numeric Rating Scale (NRS; 0 = no pain; 10 = worst imaginable pain) during training.
Time Frame: Baseline, 3, 6 and 12 weeks + 1 year follow-up
Baseline, 3, 6 and 12 weeks + 1 year follow-up
Self-reported activity level of sporting activities (hours/week)
Time Frame: Baseline, 3, 6 and 12 weeks + 1 year follow-up
Participants will self-report how many hours a week they are performing sporting activities: We will monitor to see if they decrease, maintain or increase hours per week of sporting activity
Baseline, 3, 6 and 12 weeks + 1 year follow-up
Doppler activity using Ultrasonography power Doppler
Time Frame: Baseline, 3, 6 and 12 weeks + 1 year follow-up
Using Ultrasonography, we will measure Doppler activity within the affected tendon and use ImageJ for the analysis
Baseline, 3, 6 and 12 weeks + 1 year follow-up
Tendon thickness measured using Ultrasonography
Time Frame: Baseline, 3, 6 and 12 weeks + 1 year follow-up
Baseline, 3, 6 and 12 weeks + 1 year follow-up
Muscle cross-sectional area measured using Ultrasonography
Time Frame: Baseline, 3, 6 and 12 weeks + 1 year follow-up
We will measure the muscle thickness of vastus lateralis using ultrasonography
Baseline, 3, 6 and 12 weeks + 1 year follow-up
Muscle structure measured by MRI
Time Frame: Baseline and 12 weeks
Baseline and 12 weeks
Tendon dimensions measured by MRI
Time Frame: Baseline and 12 weeks
Baseline and 12 weeks
Isometric Muscle Strength
Time Frame: Baseline, 3, 6 and 12 weeks + 1 year follow-up
Maximal muscle strength of the knee extensors is obtained during a maximal isometric voluntary contractions
Baseline, 3, 6 and 12 weeks + 1 year follow-up
Pain Pressure Threshold
Time Frame: Baseline, 3, 6 and 12 weeks + 1 year follow-up
Measured by a handheld pressure algometry at most painful site, Apex Patellar, Tibialis Anterior and Extensor Carpi Radialis.
Baseline, 3, 6 and 12 weeks + 1 year follow-up
Adverse events
Time Frame: Baseline-12 weeks + 1 year follow-up
Participants will self-report adverse events during intervention period and at 1 year follow-up
Baseline-12 weeks + 1 year follow-up
Victorian Institute of Sports Assessment - Patellar Tendinopathy
Time Frame: Baseline, 3, 6 and 12 weeks + 1 year follow-up
The VISA-P is a questionnaire that assesses symptoms, simple test of function, and the ability to play sports. Max score for asymptomatic is 100 and worst score is 0
Baseline, 3, 6 and 12 weeks + 1 year follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Mikkel Holm Hjortshøj Jensen, MSc, Bispebjerg Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2020

Primary Completion (Actual)

December 30, 2022

Study Completion (Anticipated)

September 23, 2023

Study Registration Dates

First Submitted

August 20, 2020

First Submitted That Met QC Criteria

September 14, 2020

First Posted (Actual)

September 16, 2020

Study Record Updates

Last Update Posted (Actual)

January 18, 2023

Last Update Submitted That Met QC Criteria

January 17, 2023

Last Verified

January 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Jumper's Knee

Clinical Trials on Heavy-Slow Resistance training

3
Subscribe